A patient experiences a sudden episode of severe anxiety. Of these medications in the patients medical record, which is most appropriate to give as a PRN anxiolytic?

Reasoning: Choice A reason: Lorazepam is a benzodiazepine that acts rapidly by enhancing the effects of gamma-aminobutyric acid (GABA) at the GABA-A receptor. This results in immediate CNS depression and anxiolysis, making it the gold standard for PRN (as needed) management of acute, severe anxiety episodes or panic attacks. Choice B reason: Buspirone is an anxiolytic that lacks the immediate sedative-hypnotic effects of benzodiazepines. It typically requires 2 to 4 weeks of consistent daily dosing to reach therapeutic efficacy. Therefore, it is entirely inappropriate for PRN use or the management of sudden, acute episodes of severe anxiety. Choice C reason: Tranylcypromine is a Monoamine Oxidase Inhibitor (MAOI) used primarily for treatment-resistant depression. It has a slow onset of action and carries significant risks of hypertensive crisis if dietary tyramine is ingested. It is never used as a PRN medication for acute anxiety stabilization in clinical practice. Choice D reason: Phenelzine is another MAOI antidepressant. Like tranylcypromine, it requires weeks of steady dosing to alter neurotransmitter levels and manage chronic symptoms. It provides no immediate relief for acute anxiety and involves complex side-effect profiles that make it unsuitable for emergency or PRN administration.